NCT01539226View on ClinicalTrials.gov

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

NACompletedINTERVENTIONAL
Enrollment

1,959

Participants

Timeline

Start Date

March 27, 2012

Primary Completion Date

December 13, 2016

Study Completion Date

December 13, 2016

Conditions
HIV Infections
Interventions
COMBINATION_PRODUCT

Placebo Vaginal Ring

Dapivirine Vaginal Ring containing 0.0 mg of dapivirine

COMBINATION_PRODUCT

Dapivirine Vaginal Ring, 25 mg

Dapivirine Vaginal Ring containing 25 mg of dapivirine

Trial Locations (7)

3216

Maternal, Adolescent and Child Health (MatCH), Plessislaer

3610

Prevention of HIV / AIDS (PHIVA) Project, Pinetown

7975

Desmond Tutu HIV Foundation, Guinea Fowl Road, Sunnydale, Fish Hoek, Cape Town

Unknown

Qhakaza Mbokodo, Ladysmith

MRC/UVRI Uganda Research Unit on AIDS, Plot 51-59, Nakiwogo Road, PO BOX 49, Masaka

0485

Ndlovu Medical Centre, Elandsdoorn

0250

Madibeng Centre for Research (MCR), Brits

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT01539226 - Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women | Biotech Hunter | Biotech Hunter